# FDA 483 - Integra LifeSciences Sales LLC - May 26, 2022

Source: https://www.keypedia.com/records/483/integra-lifesciences-sales-llc/d7353938-0539-433f-a69e-c0abb31851ed

> FDA 483 for Integra LifeSciences Sales LLC on May 26, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Integra LifeSciences Sales LLC
- Inspection Date: 2022-05-26
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: Integra LifeSciences Sales LLC in Cordova, TN, was cited for two observations during an FDA inspection from May 23-26, 2022. The firm failed to design procedures to prevent communicable disease risk, specifically by continuing to manufacture and release HCT/Ps despite environmental monitoring excursions. Additionally, the firm did not maintain records concurrently, evidenced by lost or missing human birth tissue allografts from their inventory system.

## Related Officers

- [Cody D. Rickman](https://www.keypedia.com/people/cody-d-rickman/54deec25-dc65-4402-991a-ad5589bad78b)

Company: https://www.keypedia.com/companies/integra-lifesciences-sales-llc/11c4b6fb-506d-43fa-90b0-ae6cf5a5dbbe

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea